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ABSTRACT 
Background: Glucose control in critically ill patients poses a challenge for all 
health care workers involved in patient management. To avoid glucose variability 
and to maintain normoglycaemia, evidence based protocols are implemented to 
guide clinical care.  However, adherence to such protocols needs to be evaluated 
on a regular basis in order to ensure efficiency of care and to improve outcomes. 
Available literature suggests that glucose control protocol compliance is generally 
poor. 
 
Aim of the study: The aim of the study was to evaluate adherence to the 
glucose control protocol by nurses in the cardiothoracic ICU at CMJAH. 
 
Objectives of the study: The research objectives were to: 
1. Describe the number of abnormal glucose readings recorded.  
2. Describe the proportion of protocol violations in relation to the glucose control 
protocol. 
3. Compare the differences in glucose protocol violations between day nursing 
staff and night nursing staff.  
4. Compare the level of training of nurses involved with glucose protocol 
violations.  
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Method:  A retrospective study reviewing the ICU charts of adult patients post 
cardiac surgery, who were admitted to the cardiothoracic ICU at Charlotte Maxeke 
Johannesburg Academic Hospital, Gauteng, during March 2011. The data was 
analysed using STATA 11 statistical software. 
 
Results: A total of 741 glucose readings were evaluated [22 patients: 13 (59.1%) 
male and 9 (40.9%) female]. The mean age of patients was 48.5 years with an age 
range of 17-76 years. The surgical procedures were categorised as: valvular 17 
(77.3%); coronary artery bypass grafts 3 (13.6%) and other 2 (9.1%). The median 
glucose reading was 7.8 mmol/l (6.7-9.3 mmol/l). Overall, 411 (55.5%) protocol 
violations were recorded if the glucose control protocol was not adhered to. Of the 
readings 629 (84.9%) were abnormal. Protocol violations were similar between the 
day and night staff; 188 (54.7%) and 223 (58.5%) respectively (p =0.256). Of the 
readings, 464 (62.6%) were done by ICU trained nurses and 246 (33.2%) by non-
ICU trained nurses. There were fewer protocol violations recorded by the ICU 
trained nurses compared to the non-ICU trained nurses, i.e. 53.3% and 63.7% 
respectively (p<0.05).  
 
Conclusion: It is concluded that adherence to the glucose control protocol in 
the ICU was sub-optimal.  Despite a high percentage of protocol violations, the 
median glucose level was 7.8 mmol/l. The number of violations committed by the 
day and night staff was similar. ICU trained nurses committed fewer violations than 
non-ICU trained nurses.  
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These results suggest that the training and education of healthcare workers in 
implementing protocols is an ongoing and dynamic process and that there is a 
need for evaluation on a regular basis. 
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CHAPTER ONE 
OVERVIEW OF THE STUDY 
1.1 INTRODUCTION 
In this chapter a brief overview of the study is provided. This includes; background 
to the study, problem statement, aim and objectives of the study, relevant 
definitions, location of the study, ethical considerations, research assumptions and 
definitions, significance, and validity and reliability of the study. Lastly, a summary 
of the chapter is provided. A more in-depth review of these topics will be presented 
in subsequent chapters. 
 
1.2 BACKGROUND TO THE STUDY 
Glucose control in critically ill patients poses a challenge for both doctors and 
nurses working in ICUs. Critically ill patients are particularly prone to 
hyperglycaemia because of metabolic and hormonal changes associated with the 
stress response (1, 2). They are also predisposed to hyperglycaemia due to 
certain clinical interventions such as the administration of corticosteroids, 
ionotropes, dextrose-containing intravenous fluids and enteral or parental nutrition 
(3). Increased blood glucose (BG) levels, even a single reading, have been 
associated with adverse outcomes in the critical care setting (4, 5).  
The Van den Berghe studies (6, 7) have shown the benefit of tight glucose control 
(TGC) using intensive insulin therapy (IIT) with respect to morbidity and mortality 
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in critically ill patients. However, further studies questioned the benefits of TGC, 
due to the increased risk of hypoglycaemia (8-11). Hypoglycaemia has been 
associated with an increased risk of hospital mortality (12-15). 
 
From an anaesthetic perspective, glucose control is particularly important during 
the peri-operative period. Surgical stress results in a hyperglycaemic response 
characterised by: “an increased production of catecholamines, growth hormone, 
glucagon and cortisol; as well as a concomitant depression in insulin levels. 
Elevated hepatic glycogenolysis and gluconeogenesis, along with reduced insulin 
secretion and tissue insulin resistance, also contribute to the hyperglycaemia (16-
18)”.   
 
Hypoglycaemia may also occur.  Surgical patients are not uncommonly fasted for 
prolonged periods of time pre-operatively or, alternatively are administered insulin 
intra-operatively. This is especially problematic when the hypoglycaemia 
symptoms are masked by anaesthesia during the peri-operative period (19).  Also, 
the brain is an obligate glucose metaboliser and severe hypoglycaemia  can cause 
neuronal necrosis (20).   
 
Maintaining an adequate glucose level intra-operatively, by an anaesthetist, is of 
particular importance in certain patients. Patients with traumatic brain injury (TBI) 
require strict glucose control as hyperglycaemia in this group of patients has been 
associated with higher intracranial pressures, longer hospital stays, poorer 
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neurological outcomes and reduced survival (21).    As part of the intra-operative 
anaesthetic goals of neuroprotection in such patients, glucose control is 
imperative.  
 
ICU admission hyperglycaemia has been shown to be an independent marker of 
mortality and morbidity (22). One study demonstrated that for every 1.1 mmol/l 
increase in the mean intra-operative glucose, the adverse outcome risk increased 
by more than 30% (23).   
 
ICUs provide ongoing care for post-operative patients when required. Most of the 
intra-operative management goals, like glucose control, are continued in ICU.  In 
doing so, continuity of care can be maintained, glucose targets safely reached and 
overall patient outcome improved. 
 
In order to ensure that glucose control is achieved in critically ill patients, 
evidence-based glucose protocols are provided in ICUs. Adherence to these 
protocols is expected, however, there may be deviations from the protocol for 
various reasons. Both organisational and individual factors contribute to the 
occurrence of violations of the protocol (24).   
According to international literature on adherence to glucose control protocols in 
ICU, Taylor et al. (25) reported a 53% adherence and Rood et al. (26) found a 
56% adherence to the paper-based glucose protocol. This poses a problem in the 
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critical care setting where morbidity and mortality may be influenced by glucose 
control. 
 
There is a school of thought that says that “clinical protocols, which assist in 
critical care decision-making, may reduce the quality of care by replacing clinical 
judgement, breeding complacency or stifling learning (27).  However, despite 
these beliefs, evidence shows that protocols can potentially reduce harmful 
variations in care, enhance efficiency and improve outcomes (28, 29)”. 
More protocols are being introduced in ICUs to improve patient care and achieve 
clinical targets. Currently, there is no literature documenting the evaluation of 
glucose protocol adherence in South African ICUs. 
 
1.3 PROBLEM STATEMENT 
The literature suggests that glucose control in ICUs has important morbidity and 
mortality implications. Achieving normoglycaemia during this hypermetabolic state, 
while avoiding hypoglycaemia, is a challenging task.  Protocols are in place to help 
achieve glucose targets, however, they may not always be followed.  “The use of 
protocols simplifies processes, standardises care, facilitates patient safety and 
reduces costs, but lack of compliance can hinder the success of any protocol 
(30)”.  Protocols for glucose control are in place in the ICUs at Charlotte Maxeke 
Johannesburg Academic Hospital (CMJAH) but adherence to these protocols has 
not been evaluated in the cardiothoracic ICU at this institution.  
 
5 
 
Health care workers (HCWs) working in the ICU are from various academic 
backgrounds. Additionally, the nurses are not all ICU trained and many are agency 
nurses, who are employed due to permanent staff shortages.  In a national audit of 
critical care resources in South Africa, it was found that the majority (49%) of 
nurses working in critical care units in South Africa, were registered nurses without 
critical care training and with less than 5 years’ experience (31). Specifically, the 
cardiothoracic ICU at CMJAH was found to be staffed by more than 50% with non-
permanent staff, who were employed via agencies on a temporary basis  (32).  
 
1.4 AIM OF THE STUDY 
The aim of the study was to evaluate adherence to the glucose control protocol by 
nurses in the cardiothoracic ICU at CMJAH. 
 
1.5 OBJECTIVES 
The research objectives were to: 
• Describe the number of abnormal glucose readings recorded.  
• Describe the proportion of protocol violations in relation to the glucose control 
protocol. 
• Compare the differences in glucose protocol violations between day nursing 
staff and night nursing staff.  
• Compare the level of training of nurses involved with glucose protocol 
violations.  
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1.6 RESEARCH ASSUMPTIONS AND DEFINITIONS 
The following definitions were used in this study. 
Intensive Care Unit (ICU) – “A hospital unit where patients require close 
monitoring, which contains highly technical, sophisticated monitoring devices and 
equipment and which is staffed by personnel who deliver critical care (33)”. 
Adult patients - Patients who are 16 years and older. 
Glucose protocol – “Protocols are a means of formalising how to perform a 
specific procedure (34)”. Glucose protocols are specific, prescribed instructions for 
ICU staff regarding glucose control. The protocols can be either a sliding scale or 
infusion instructions (Appendix F and G respectively) 
Adherence - For the purpose of this study, adherence is defined as the correct 
action being performed in accordance with the protocol. 
Violation - Any treatment or non-treatment action in terms of the glucose level that 
is not in accordance with the glucose control protocol. 
Hypoglycaemia - A blood glucose reading less than 3.5 mmol/l. 
Hyperglycaemia – A blood glucose reading of more than 10 mmol/l. 
Normoglycaemia – A blood glucose reading in the range 3.6 - 9.9 mmol/l. 
 
1.7 LOCATION OF STUDY 
The study took place at the cardiothoracic ICU at CMJAH, Gauteng Province, 
South Africa. This is a quaternary, academic hospital associated with the 
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University of Witwatersrand. It is the only public sector cardiothoracic ICU in 
Johannesburg. On average 21 operations are performed every month with a 
nurse: patient ratio of 1:1 in this unit. 
 
1.8 ETHICAL CONSIDERATIONS 
The proposal for this study was submitted to the Postgraduate Committee of the 
University of the Witwatersrand for approval (Appendix A).  
 
Ethical approval for this study was obtained from the Human Research Ethics 
Committee (Medical) of the University of Witwatersrand (Appendix B). 
 
Approval for this study was received from the HOD of critical care at CMJAH. 
(Appendix D) 
 
In addition, a written informed consent was obtained from the Chief Executive 
Officer of CMJAH to conduct the research in the hospital and specifically to gain 
access to, and utilize, patients’ records (Appendix C). 
 
The researcher only worked with the numbers allocated to patients and not with 
the file numbers or patient names (data collection sheet-appendix E). This ensured 
confidentiality, privacy and anonymity of patient information. 
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Furthermore, anonymity of HCWs working in ICU during the month of March 2011 
was maintained as numbers were allocated to them. The numbers, not the names, 
were used when cross-checking ICU charts and the researcher only knew the 
identity of the health care workers (data collection sheet-appendix F). The 
researcher and supervisor were the only people who had access to raw data for 
this study.  
 
Data will be stored for a minimum of 2 years after publication of this study or for 6 
years in the absence of publication of the results of this study. 
 
The retrospective nature of the study does not allow the researcher to intervene 
with any patient treatment. 
 
The study was conducted in adherence with the principles of the Declaration of 
Helsinki (35). 
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1.9 RESEARCH METHODOLOGY 
1.9.1 Study Design 
A retrospective, contextual, single-centre, descriptive research design was 
followed in this study.  
 
1.9.2 Study population and study sample  
The ICU flow charts of all adult patients admitted to the cardiothoracic ICU at 
CMJAH during the month of March 2011 and the demographics of the nurses 
working in the unit during that period constituted the study sample.  
 
1.9.3 Study sample 
A convenience consecutive sampling method was used.  
 
1.9.4 Inclusion and exclusion criteria 
Inclusion criteria were the ICU flow charts of all adult patients, 16 years and older, 
who were admitted to the CT ICU during the month of March 2011. The 
demographic data of nurses looking after those patients were also collected. There 
were no exclusion criteria. 
 
1.9.5 Data collection procedures 
Two data collection sheets were used; one for the collection of data from the ICU 
flow charts of patients admitted to the CT ICU during March 2011; and one to 
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capture the demographics of the nurses looking after those patients during the 
research period (Appendix I and F respectively). 
 
Protocols utilised in the ICU during the research period are defined in Appendix G 
and H. 
 
1.9.6 Statistical Analysis 
The researcher collected the raw data, personally, and entered it onto a Microsoft 
Excel spreadsheet. The data was then analysed with the aid of a biostatistician 
using the software programme STATA 11 (STATA Corporation, College Station, 
TX USA).  
 
1.10 SIGNIFICANCE OF THE STUDY 
Hyperglycaemia at the time of admission to ICU is an independent risk factor for 
in-hospital mortality (36). Adequate glucose control has been associated with 
improved patient outcome. However, despite the adoption of protocols by ICUs, 
questions about the adherence to such protocols remain unanswered.  
Identifying the shortcomings of a protocol that has already been implemented, 
would be beneficial in the development and implementation of future protocols for 
that unit.  
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1.11 VALIDITY AND RELIABILITY OF THE STUDY 
Validity is the extent to which an instrument actually reflects or measures what it is 
supposed to measure (37).  Content validity was secured by literature review, 
experts in intensive care, a biostatistician and a research methodologist. 
 
Reliability is concerned with how consistently the measurement technique 
measures a variable or concept (37). The data was collected, from patient records, 
by a single researcher only. This ensured that the data was collected in a 
standardised manner and that it was reliable. 
 
1.12 POTENTIAL LIMITATIONS OF THE STUDY 
The results from this study’s population were contextual and may not be applicable 
to other ICUs. 
 
The accuracy of bedside glucometers,  i.e. point-of-care instruments, for 
measuring lower blood glucose levels has been questioned (38). Ideally, to 
prevent disparities caused by different glucose-measuring methods, a single 
standardised method should have been used. 
 
Also, one needs to consider the limitations of a retrospective study, which relies on 
the accuracy of written record or the recall of individuals (recall bias), as well as 
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legibility and availability of records. Determining the nursing demographic data 
posed a challenge, as data were obtained from poorly kept shift records.  
Therefore there was possibly a loss of important data and a possibility of 
inaccurate data being collected. 
 
1.13 PROJECT OUTLINE 
Chapter one presents an overview of this research report. Chapter two includes an 
in-depth literature review of the research topic. Chapter three contains a 
comprehensive discussion of the research methodology. Chapter four includes a 
presentation of results and discussion thereof. The final chapter provides the 
conclusion of the study as well as further recommendations. 
 
1.14   SUMMARY 
This chapter provided a brief overview and summary of this research report. 
Topics covered included introduction and background, problem statement, aim 
and objectives, research assumptions, location of the study, ethical 
considerations, research methodology, significance of the study, validity and 
reliability, potential limitations and the project outline. A more comprehensive 
review of the topics is presented in subsequent chapters. 
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CHAPTER TWO 
LITERATURE REVIEW 
2.1 INTRODUCTION 
In this chapter, various concepts relating to glucose control in ICU are reviewed. 
First evidence-based practice (EBP) is described. Secondly, protocols and the 
different aspects of their development and implementation are provided. Next, a 
review is provided of: glucose control, glucose control in critically ill patients, 
glucose targets, measuring glucose in critically ill patients, insulin administration 
versus glucose control, glucose control protocols and lastly from tight glucose 
control (TGC) to Safe effective glucose control (SEGC). 
 
Medicine and the practise thereof, is not an exact science and is an ever-evolving 
discipline.  The ultimate aim of health care practitioners’ is good patient outcome. 
In order to achieve desired clinical goals, the use of EBP is being advocated in 
most medical disciplines.  
 
2.2 EVIDENCE-BASED PRACTICE 
The most widely used definition for EBP is that of Sackett et al. (39).  EBP is 
defined as: “The conscientious, explicit and judicious use of current best evidence 
in making decisions about the care of individual patients.” The definition further 
indicates that: “The practice of evidence-based medicine requires the integration 
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of individual clinical expertise with the best available external clinical evidence 
from systematic research and our patient's unique values and circumstances”. 
 
“EBP requires a shift from the traditional paradigm of clinical practice grounded in 
intuition, clinical experience and pathophysiological rationale (40)”.  There is now a 
shift from “authority” or “opinion” based practice to EBP.  
 
Multi-disciplinary teams are now more involved in patient care. EBP can therefore 
be used, with evidence as the levelling factor amongst the various teams, with 
care discussions centring around the evidence - rather than “this is the way we do 
things around here” or “that is the way the surgeon prefers to do things” (40).   
 
Reliance on experience or the opinion of colleagues is not likely to guarantee that 
the “best science” or “current evidence” is integrated into practice (40).  
Recommendations, based solely on clinical judgement and experience, are likely 
to be more susceptible to bias and self-interest (41).  When healthcare is delivered 
with an organisational culture that supports best practice, EBP is linked to a higher 
quality of care and with better patient outcomes than care that is heavily weighted 
in tradition (42).   
 
A common observation when reviewing healthcare services is the gap between 
evidence and practice (43). Despite healthcare organisations advocating that the 
use of EBP should be the standard of practice of care, most clinicians in do not 
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consistently implement evidence-based care (42, 44).  Approximately less than 
20% of medical practice is backed up by solid evidence (45). 
 
EBP involves doing a literature search relevant to the patient condition, evaluating 
the literature for its credibility and finally applying the findings to assist with your 
decision making. It is by going through this systematic process that the quality of 
patient care can be enhanced (46).  
 
“Multiple barriers have contributed to the slow uptake of EBP across healthcare   
systems, including: (a) inadequate knowledge and EBP skills of healthcare 
professionals; (b) misperceptions about EBP; (c) lack of informatics competencies; 
(d) insufficient administrative support and resources at the point of care; (e) lack of 
EBP mentors in healthcare systems and; (f) traditional approaches to teaching 
healthcare students, i.e. the rigorous process of how to do research, rather than 
how to use research to guide best practice (47-49)”. 
 
Some studies have found that EBP improves the quality of care of patients and 
their outcome, enhances practitioner skills, decreases practice variation and 
healthcare costs (50-52). “Other outcomes that can be derived from the EBP 
process include clinical practice guidelines; protocols; and standards (53); all of 
which may lead to; (a) greater consistency in the care provided; (b) greater patient 
satisfaction due to improved outcomes and; (c) a higher quality of care and 
healthcare provider satisfaction (54)”. 
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Protocols can be an effective method of introducing EBP into ICUs and evidence 
shows a decline morbidity and mortality and decrease the cost of critical illness 
when implemented (28, 55). 
 
2.3 PROTOCOLS - DEFINITIONS, ADVANTAGES, 
DISADVANTAGES AND ADHERENCE 
The terms algorithms, protocols, clinical guidelines and care or clinical pathways 
are sometimes used interchangeably therefore it is important to clarify the 
differences and similarities between them.  Clinical care processes help to 
standardise and simplify care for patients and their conditions (56). 
 
• “Algorithms provide a step-by-step procedure and instructions for clinical 
decision-making or problems (57, 58). 
• Protocols are a means of formalising how to perform a specific procedure (34). 
• Clinical guidelines have been defined as systematically developed statements 
that assist practitioner and client decisions about appropriate health care for 
specific clinical circumstances (59). 
• Care pathways are a way of organising care for a well defined group of 
patients during a well defined period of time (60, 61)”. 
Whilst standardisation and organisation are common to all these care processes, 
the degree of specificity between them varies.  
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“Algorithms provide very detailed information, usually presented in a flow chart, of 
what to do at each step of the decision making process (62). Protocols also 
provide detailed information about a particular process or procedure, but do not 
usually have the same degree of detail as algorithms (63)”.  
 
Clinical guidelines contain more “operational detail than algorithms, as they are 
made up of recommendations that describe different aspects of the patient’s 
condition and appropriate management options” (64). “A care pathway, however, 
may be described as a hybrid of an algorithm, protocol or guideline”. This will 
generally cover the whole patient journey for a specified period of time and may 
also contain protocols, algorithms and standards (34, 65). 
 
Swinglehurst (66)  implores that a delineation be made as protocols are more rigid 
and provides little room for individual judgement than guidelines. Protocols tend to 
be clear rules which must be followed, compared to guidelines which aim assist 
with clinical decisions being made. 
 
Evidence-based protocols are used in the critical care environment to address 
multiple aspects of care and to guide the treatment of many conditions (67), for 
example, glucose control protocols. Health care delivery may to be too dependent 
on the individual clinician’s knowledge, motivation and skills, with the result that 
only approximately half of the patients receive the recommended care (68).  The 
high cost of intensive care medicine, along with the significant morbidity and 
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mortality of specific, high volume admissions and diagnoses, have prompted 
governmental institutions, researchers and intensive care societies to seek 
standardised diagnostic and treatment protocols in order to reduce practice 
variation and improve the quality of care (29, 69, 70).   
 
Currently, in order to assess the delivery of the quality and consistency of care in 
the critical care setting and other medical disciplines, surrogate markers such as 
checklists, protocols and integrated care pathways are used (71). 
 
Several investigators have proven that protocol driven therapeutic action 
beneficially impacts patient outcome in the ICU (72-75).  However, one also needs 
to take into consideration that a standard care pathway/protocol is ideal for many, 
yet should not be viewed as “tablets of stone” (71).  The pathophysiology of 
critically ill patients is complex, with inter-individual differences (including age, 
disease processes, co-morbidities, drug responses, etc.) making standard care 
unsuitable for everyone.  
 
Roffey et al. discuss overuse of protocols in ICU and suggest that protocols may 
result in the simplification of patient care on a large scale. They are of the opinion 
that each patient will respond differently to each situation and that even drugs 
used routinely may not have a place in the care of certain patients on specific 
occasions. Patients may respond better or worse than expected to a specific 
pharmacological intervention, be it an ionotrope or sedative medication.   
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Furthermore, they put forward the concept of the increased use of protocols 
impacting on the traditional practice of the doctor–patient relationship and there 
being less hands-on physician interaction with critically ill patients (76).  
Many physicians would agree with this school of thought and are wary of a 
standardised approach and some feel that protocol-driven care may jeopardise the 
decision-making skills of the profession, especially in a highly technological era in 
which physician bedside skills may have already reached a peak (27).  According 
to Considine et al. (77), clinical guidelines and protocols intend to facilitate and 
guide, but not completely replace, clinical decision making. 
 
Many clinicians want to improve their quality of patient care but often lack an 
understanding on the process of how to initiate change in order to implement 
change. This knowledge deficit has been termed ‘change-process illiteracy’ (78). 
Although most ICU physicians have a good knowledge of patient pathology, few of 
them possess the formalised training in systems thinking, the process of quality 
improvement regarding the change of practice and outcomes measurement (78-
82).  Therefore it is important to identify and understand the non-physiological 
factors that affect protocol compliance. 
 
A recent study by Chase et al. (83), looked at the role of human factors and how 
individuals relate to technological protocols in clinical settings.  It was found that 
most issues that affect adherence are often unrelated to the patient or treatment; 
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instead they are a function of the protocol design and its ability to integrate into a 
given clinical setting. 
 
There are four specific human factors or issues have been identified that can 
affect adherence and/or performance i.e.:  
• “Management and collaboration. The relationship amongst nursing staff, 
doctors, pharmacists and hospital management can affect collaboration, 
especially if there is not a multi-disciplinary approach or no clinical leader (84-
87). 
• Clinical burden, i.e. the time and effort needed to administer a protocol. 
Complex protocols or those needing many interruptions, trips from the 
bedside, extensive data management or outside input can affect adherence 
directly (85-90). 
• Transparency. Complex protocols, difficult interfaces and frequent protocol 
violations or changes serve to: reduce consistency, remove insight into how 
the protocol works, and decrease trust in the protocol. These are important for 
good adherence to the guideline and reducing working outside the protocol 
(85,87-91). 
• Training and education. The level of training and education affects both 
transparency and the clinical effort required. Regular in-service training can 
also improve the efficiency of care and adherence to a protocol in longer term 
use (84,92-96)”. 
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There are a few theoretical frameworks that could be applied to describe 
procedural non-adherence in health care. These frameworks have different origins 
and consequentially lead to different types of analyses of the origins of violations 
(24). 
  
In 1997 Reason (97) described a framework and distinguished non-adherent 
behaviour as being either intentional or non-intentional. In an intentional case, 
non-adherence defines a violation, whereas non-intentional, non-adherent 
behaviour is an expression of human error (97).  Both organisational and individual 
factors contribute to the occurrence of violations (98).   
 
The types of violations include routine violations, corporate violations, exceptional 
violations, necessary violations and optimising violations (99). Reason (97) 
explained that routine and optimising violations were related to personal 
characteristics and necessary violations were related to organisational failure. 
“Routine violations are violations that occur when a person perceives an 
alternative, more efficient way of dealing with a task than the way a policy or a 
protocol requires”. He stated that these violations are common and often tolerated.  
 
“Corporate violations result from administration creating a situation that supports 
the violation of procedures (e.g. excessive working hours)”.  “Exceptional 
violations occur in unusual or exceptional circumstances in which a routine cannot 
be followed”. Optimisation violations are those where additional motives are 
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involved. This category involves a person being motivated by personal goals, 
performing experimental treatment and performing unnecessary procedures (97-
99).   
 
Violations are an important part of a model of human behaviour and a breakdown 
in performance (24). By applying Reason’s systems approach to protocol 
violations (rather than the more common “person” approach of placing blame), it is 
possible to understand the overall picture of the cause of the violation in question 
(97). 
 
Carthey, (a human factors consultant), Walker (an anaesthetic registrar), and other 
colleagues from the Imperial College of London, were concerned about the 
burgeoning number of protocols and guidelines used to standardise and clarify 
care. They subsequently published an analysis into understanding non-compliance 
with protocols and guidelines (100).  It was found that there was a reduction in 
adherence to protocols and guidelines due to various factors.  Staff may: break the 
rules if the protocol is complex and lengthy; not follow the protocol because they 
are unaware of it because of it was held in an unknown place or inadequate 
distribution of the protocol.   
 
There may be multiple versions of the same protocol which could be the reason for 
following the wrong protocol.  Protocols often need to be updated according to the 
latest evidence-based literature however previous versions may remain in 
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circulation.  Sometimes there are multiple protocols on the same topic, which 
leaves healthcare professionals unsure about which protocol to follow (100).  
 
According to Carthey et al (100), sometimes new protocols are introduced as a 
reflex to a specific incident.  As a result, insignificant protocols may be developed 
that can affect staff morale and willingness to comply with other important 
protocols (100). Human factors research across several industries has shown that 
if more rigid protocols are imposed on healthcare workers, the less likely they are 
to comply with them (101, 102).  Humans are also naturally adaptable and tend to 
improvise, which makes some non-adherence inevitable (103). 
 
Importantly, in our local context, the shortage of skilled nurses poses a problem in 
the critical care setting.  In 2007 a national audit of critical care resources in South 
Africa was conducted and it was found that only 14.5% of nurses working in ICU 
were actually ICU trained (31).  A large portion of nurses (43%) had 0-5 years of 
ICU experience (31). A suggestion by Bhagwanjee et al (104), to reduce the 
impact of the shortage of nursing skills, is the implementation of protocols and 
guidelines in ICUs . 
 
A study by Perrie (105) in 2006 looked at the level of knowledge of intensive care 
nurses, working in South African ICUs, with regards to specific care protocols 
commonly used. Results showed that the level of knowledge was well below the 
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competency indicator of 70% determined by ICU experts.  With regards to 
knowledge about glucose control, the average score was 48.7%.   
Evaluation of the knowledge of doctors working in ICU has not been researched 
but is an important area that needs to be explored. 
 
These are pertinent aspects to consider when looking at protocol adherence.  If 
one does not understand a protocol, how then can it be effectively adhered to? 
Furthermore, how does it influence the development and implementation of 
protocols? 
 
2.4 PROTOCOLS - DEVELOPMENT AND IMPLEMENTATION 
Human factors play a significant role in protocol adherence therefore human 
factors science should be applied to the development and design, implementation, 
testing and evaluation of policies and guidelines (100).   
 
Despite the methods of guideline development being complex (106), it must be 
ensured that when implemented, desired patient outcomes may be achieved.  
There are different recommendations to protocol and guideline development but 
the salient points remain common throughout. 
 
“Shekelle et al (107) presented five initial steps in the development of an evidence-
based guideline: 
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• identification and refinement of the subject area 
• convening and running guideline development groups 
• assessment of the evidence about the clinical question or condition 
• translation into a recommendation within a clinical practice guideline 
• external review of the guideline”. 
 
At the start of any development process it is imperative that a multi-disciplinary 
team is utilised.  This ensures that all stakeholders involved with implementing the 
protocol are also part of its development.  Chan et al (108) commented on their 
staff’s perception of increased autonomy and desire to assist with protocol 
compliance.  This was attributed to them being incorporated into the multi-
disciplinary which was an integral part of the development and implementation of 
the protocol. It appears that health care professional involvement in the 
development process is imperative for the uptake and compliance of the protocol 
being implemented. Some literature provided evidence that guidelines will only be 
utilised by healthcare workers if they felt that they had been part of its 
develpoment (109, 110).  Rees et al (111) puts forward that one of the reasons for 
the lack implementation of a protocol was that the staff felt that they were not 
involved in the development process. 
 
Equally important in the protocol or guideline development process is taking into 
account the local context into which the guideline will be implemented (112).  Also 
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to be considered are the available resources and the feasibility of implementing 
such a protocol or guideline. 
“The development of good guidelines does not ensure their use in practice (113). 
Systematic reviews of strategies for changing professional behaviour show that 
relatively passive methods of disseminating and implementing guidelines, by 
publication in professional journals or mailing to targeted healthcare professionals, 
rarely lead to changes in practitioners’ behaviour (114, 115).  Lomas et al (116) 
observed that the failure of passive dissemination strategies is unsurprising given 
that many factors influence healthcare professionals' behaviour”. 
 
Research shows that the implementation of clinical guidelines requires time, effort 
and resources (113).  Most healthcare organisations do not have the resources 
and skills to develop valid guidelines from scratch (41, 117). They should try to 
identify previously developed guidelines and adapt these for local use (41). 
Furthermore, when an organisation has identified relevant guidelines in the 
literature, the validity should be appraised before deciding to adopt the 
recommendations (113). 
 
There is no one, efficient way to ensure the implementation of new guidelines in 
clinical practice (118, 119) therefore, a multifaceted approach should be used.  
The choice of strategies should be informed by the available resources, perceived 
barriers to care and research evidence about the effectiveness and efficiency of 
each of the different strategies (120). 
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The developed protocol or guideline should be externally reviewed to ensure 
content validity, clarity and applicability (41).  Thereafter, there should be 
appropriate revision of the guidelines on a regular basis (121). 
 
Protocols are commonly used to guide care in ICUs e.g. glucose control protocols. 
 
2.5 GLUCOSE CONTROL 
Numerous protocols have been implemented in ICUs worldwide. Whether these 
protocols are adhered to as prescribed is not always clear. Glucose control 
protocols, whether paper or computer based, and the range of glucose control that 
they target has been controversial.  
 
Up until the late 1990’s, clinicians viewed stress hyperglycaemia as a beneficial 
defence mechanism of the body (122).  It was accepted for many decades as an 
adaptive response to physiological stress i.e. a compensatory mechanism to 
provide fuel to vital organs (123). The importance of glucose control in 
postoperative patients was first demonstrated by Furnary and associates (124) and 
later confirmed by Van den Berghe et al (7).  
 
The large, landmark study by Van den Berghe et al in 2001 (7), a single centre 
randomised control trial involving 1548 patients, most of whom had undergone 
cardiac surgery, was instrumental in questioning the acceptance of 
28 
 
hyperglycaemia in critically ill patients.  TGC between 4.4 and 6.1 mmol/L was 
targeted by IIT (intensive insulin therapy) using a paper-based protocol for insulin 
infusion. This represented a huge change in mindset regarding glucose control.   
 
The impact of IIT showed: 
• an absolute mortality reduction in ICU from 8% to 4.6% 
• a significant reduction in the incidence of multi-organ failure and the need for 
renal replacement therapy 
• less ventilator dependence 
• less liver impairment 
• a 44% reduction in critical illness polyneuropathy 
• a 41% reduction in renal failure 
• reduced sepsis related morbidity 
• reduced blood transfusions (7). 
 
In a subsequent study involving 1200 patients, Van den Berghe et al (6) reported: 
• reduced morbidity in patients admitted to a medical ICU  
• mortality benefits were only seen in patients treated with IIT for 3 days or 
longer 
• 18.7% risk of hypoglycaemia. 
Confirmation of the mortality benefit of TGC was confirmed in a mixed medical-
surgical ICU setting by Krinsley et al (125, 126).  Furnary et al (127) and Lazar et 
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al (128) both showed improved patient outcomes with TGC in patients undergoing 
cardiac surgery. 
 
An era of TGC then began where centres around the world targeted tighter 
glucose ranges.  In addition, numerous organisations and societies published 
protocols that promote the attainment of normoglycaemia or near-normoglycaemia 
in the ICU setting (129-132).   
 
Attempts to replicate the results of the early studies raised concerns about the 
safety of TGC.  Similarly, two smaller single centre studies from Saudi Arabia and 
Colombia failed to demonstrate benefit from IIT (133, 134). The debate was further 
fuelled by the premature cessation of two large randomised control trials, VISEP 
and GLUCOCONTROL due to unacceptably high rates of severe hypoglycaemia 
(8, 9). 
 
Adding to the controversy were the results from the most recently published NICE-
SUGAR trial, the largest randomised control trial to date.  They showed that TGC 
was associated with a 14-fold increase in hypoglycaemia compared with the 
moderate glucose control group.  Subsequently, two meta-analyses also 
demonstrated that severe hypoglycaemia increased the likelihood of mortality six-
fold (135, 136).  The evidence could not be ignored and the concern for 
hypoglycaemia resulted in guidelines suggesting more measured, less aggressive 
glucose control and higher glucose target ranges (135-137). 
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In order to understand the benefits of glucose control, the dynamics of glucose 
and insulin interactions in critically ill patients need to be understood.  
 
2.6 GLUCOSE AND INSULIN INTERACTIONS WITH CRITICAL 
ILLNESS 
“Critical illness promotes a state of insulin resistance which is characterized by 
increased hepatic gluconeogenesis and glycogenolysis, impaired peripheral 
glucose uptake and higher circulating concentrations of insulin (138). Elevated 
levels of cytokines and counter-regulatory hormones such as glucagon, cortisol, 
growth hormone and catecholamines trigger upregulation of hepatic glucose 
production (139-141).  Exercise-stimulated glucose uptake in skeletal muscle 
plummets as patients become bedbound (142). Impairments in glycogen synthase 
activity limit glucose uptake by heart, skeletal muscle, and adipose tissue. 
Furthermore, insulin stimulated glucose uptake by carriers such as GLUT- 4 is 
diminished (143, 144)”. 
 
These pathophysiological processes serve to elevate glucose levels during critical 
illness. However, this has been found to be to the detriment of these patients. 
 
2.7 DELETERIOUS EFFECTS OF HYPERGLYCAEMIA 
“Hyperglycaemia has immunomodulatory effects including increased production of 
anti-inflammatory cytokines like interleukin 10 (IL-10), promotion of mitochondrial 
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dysfunction (145) and impairment of polymorphonuclear neutrophil function 
resulting in decreased intracellular bactericidal activity, opsonic activity, and innate 
immunity are examples of these (124, 146-148)”.  
 
“Hyperglycaemia promotes inflammation by increasing pro-inflammatory cytokines 
such as TNF-alpha, interleukins (149), increasing leucocyte adhesion molecules, 
inducing nuclear factor kappa B (150) and promoting the procoagulant state (124, 
146-148)”.   
 
Hyperglycaemia can lead to significant oxidative stress (151-153).  A recent study 
showed that hyperglycaemia exacerbates lung injury when using intravenous 
lipopolysaccharides rat model of acute lung injury (154). 
 
Hyperglycaemia also “induces the formation of advanced glycation end products 
which are now recognised to promote inflammation and endothelial dysfunction 
(155).  The interaction of AGE and receptors for AGE (RAGE) have been 
implicated in endotoxin-induced ALI (156) and shown to modulate outcomes in 
septic shock (157).  Although AGEs can be difficult to measure experimentally, 
RAGE appears to be a marker of Type I cell injury in ALI (158) and a recent acute 
respiratory distress syndrome (ARDS) network study demonstrated that higher 
circulating levels of RAGE was associated with severity of lung injury and clinical 
outcomes (159). These experimental and clinical data provide biologic plausibility 
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for why glucose control and insulin treatment may be important in improving 
morbidity and mortality in diverse states of critical illness (123)”. 
 
Not only are there benefits of maintaining normoglycaemia in critically ill patients, 
but there are also benefits of insulin administration. 
 
2.8 Insulin effects 
Insulin has a number of non-glucose metabolic effects that may be important in 
critical illness: 
• “modulates inflammation 
• reduces free fatty acids and reverses the state of dyslipidaemia in critical 
illness 
• regulates apoptosis 
• prevents endothelial dysfunction and hypercoagulation 
• decreases neutrophil chemotaxis and leukocyte adhesion via reduction of 
ICAM-1 and macrophage inhibiting factor 
• attenuates the catabolic state of critical illness 
• prevents excessive nitric oxide which may help regulate oxidative stress (123, 
160-167)”. 
In order for the correct insulin dose to be administered, the correct glucose level 
needs to be measured. 
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2.9 MEASURING GLUCOSE IN CRITICAL ILLNESS 
There are various methods of measuring blood glucose.  The most common being 
the point-of-care glucose meter readings from a capillary “fingerstick”, but arterial 
and venous samples are also used, especially when invasive lines are in place 
(123). 
 
It is important as physicians looking at glucose levels to know the site from which 
the sample was taken and the device used to measure the glucose level (eg. 
blood gas analyser versus central hospital laboratory versus glucose meter 
machines) as the readings may not all correlate.  Sometimes the values may be of 
such significance that clinically relevant changes in insulin titration may occur. 
Research by Kanji et al (168) provided more confirmatory evidence that clinically 
relevant differences exist between different methods of glucose measurements. 
 
Bedside capillary glucose meter readings “tended to systematically overestimate 
blood glucose (BG) values, which is important to note, as this may lead to delayed 
recognition of hypoglycaemia in clinical practice (123). This tendency for 
systematic overestimation of capillary readings has been noted in other studies as 
well (169-171)”.  A number of factors that are commonly encountered during 
critical illness can affect point-of-care blood glucose measurements which include: 
• “blood source: serum, plasma, whole blood 
• blood sampling site (capillary blood differ from venous by as much as 3.8 
mmol/l) 
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• amount of blood on glucometer strip 
• Too much results in spuriously high levels 
• Too little results in spuriously low levels 
• haematocrit (progressive anaemia results in spuriously high levels in whole 
blood assays) 
• peripheral hypoperfusion: shock states, vasoconstriction, dehydration, 
vasospastic disorders 
• sample processing delay 
• substances reported to interfere with glucose measurements e.g. dopamine, 
mannitol, acetaminophen, severe lipaemia etc (172)”. 
 
It has been well validated that glucose control be achieved in critically ill patients 
but within what range should it be maintained? 
 
2.10 GLUCOSE TARGETS 
It is challenging to develop EBP guidelines when the results from various clinical 
trials are conflicting. There is agreement in the literature that very high glucose 
values are not acceptable but to what degree the glucose should be controlled is 
still debated. 
 
After appraising the various studies that had emerged the American Association of 
Clinical Endocrinologists and the American Diabetic Association revised their 
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recommendations for glucose targets. A summary of their recommendations in the 
critically ill are: 
• insulin infusion preferred 
• starting threshold not higher than 10 mmol/l 
• maintain BG 7.8-10 mmol/l (greater benefit likely at lower end of this range) 
• lower targets may be appropriate in selected patients if already being 
successfully achieved 
• < 6 mmol/l NOT recommended (not safe) (137). 
The 2009 online update from the Surviving Sepsis Campaign committee closely 
resemble these recommendations with a goal BG approximating 8 mmol/l (173). 
 
However, due to different pathologies and the pathophysiology of critical illness 
being so dynamic, the same glucose targets cannot be standard for every critically 
ill patient.   
 
Griesdale et al (135) suggested surgical ICU patients, especially those undergoing 
elective surgery, can still benefit from tighter glucose control as opposed to 
medical ICU patients.  The literature also suggests the benefits of strict glucose 
control post cardiac surgery (6, 124, 127, 174). 
 
Locally, the Nesibopho Best Practice Guidelines (175) on glucose control in ICU, 
which is endorsed by the Critical Care Society of Southern Africa, recommends 
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the maintenance of glucose to be < 8.1 mmol/l but if monitoring is inadequate and 
/or hypoglycaemia occurs, maintenance should be between 7-9 mmol/l. 
 
Despite obtaining optimal BG levels and maintaining them, avoidance of large 
variations should also be achieved. 
 
2.11 GLUCOSE VARIABILITY 
Glucose variability is a way of characterising the fluctuations of glucose values and 
has been identified as a prognostic indicator of worse outcomes in known diabetic 
patients (176). Glucose variability has been associated with increased mortality 
especially in critically ill patients (177).  Glucose control should also incorporate 
glucose variability and not only single readings (176). 
 
Much controversy surrounds the question of which is more beneficial; the amount 
of insulin administered or the level of glucose control achieved? 
 
2.12 INSULIN ADMINISTRATION VERSUS GLUCOSE CONTROL  
“Van den Berghe et al (178) performed a multivariate logistic regression analysis 
on the data derived from their series of postoperative patients undergoing 
mechanical ventilation and determined that the degree of glucose control, rather 
than the quantity of insulin administered, was associated with the decrease in 
mortality and organ system dysfunction”. The issue of whether increased insulin 
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administration or glucose control per se is responsible for Van den Berghe’s highly 
positive outcomes has however been debated (180-182). 
 
Finney et al (179) conducted a study involving a cohort of 523 patients, 
predominantly undergoing cardiac surgery, and found that there was a positive 
correlation between mortality and the amount of insulin given irrespective of the 
blood glucose level.  
 
2.13 GLUCOSE PROTOCOLS 
In recent years, a large number and variety of protocols have been formulated, 
each adapted to local practices and need.  The development and implementation 
of glucose control protocols demonstrate huge variance across different sites and 
therefore need to be assessed closely when interpreting results of studies (176). 
“Heterogeneity of patient populations and therapeutic regimens impede universal 
adoption of one protocol” (183) . A few of the differences amongst existing 
protocols include: route of administration, computerised versus written glucose 
control protocols and various healthcare providers determining the appropriate 
titration (183). 
Protocols that adjust insulin dose, taking into account the degree of 
hyperglycaemia as well as the direction and rate of change from the previous 
measurement, are favoured (123). Analysis of available protocols and their 
performance led Meijering et al (183) to conclude that ‘dynamic protocols’ had 
better efficacy and safety when compared to ‘static sliding scale protocols’. Also, 
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fewer hypoglycaemic episodes have been reported when IIT protocols were 
managed by nurses rather than adjusted by the prescriber (176). 
 
Computerised protocols are potentially beneficial in comparison to written 
protocols as complex calculations can be performed rapidly by computerised 
models and many computerised insulin algorithms factor velocity of glucose 
change into consideration (176). Characteristics of an evidence-based, safe insulin 
administration protocol include a nursing-managed, computerised dynamic system 
(176). 
 
Protocols which are changed to apply to local practices need to follow the data to 
ensure that hypoglycaemia rates are reduced, adverse events found and 
analysed, and that glucose targets are being met. Also it is important to review 
feedback from nursing staff regarding obstacles that may inhibit smooth running, 
lead to frustration, and add to many protocol violations (123). 
 
Important variations to glucose protocols include nutrition and concurrent 
medications.  These need to be considered when assessing a protocol’s success 
and equally important, when the protocol is implemented.  For example, in the Van 
den Berghe et al. trial (6, 7) patients were mostly fed by the parenteral route and 
received large doses of intravenous glucose.  In comparison, many patients in 
further trials received nutrition mostly via the enteral route.  
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Corticosteroids also influence blood sugar. In the medical ICU study by Van den 
Berghe et al (6), approximately half the patients in each arm of the study received 
corticosteroids while this number was closer to a third in the NICE-SUGAR trial 
(184). 
 
There is now a move away from TGC.  Safe Effective Glucose Control (SEGC) 
has been suggested as an alternative. 
 
2.14 FROM TGC TO SEGC 
Krinsley and Preiser (185), two health care practitioners at the forefront of ongoing 
glucose studies, are concerned about the clinical burden of TGC. “TGC demands 
a complex application of monitoring and dynamic treatment throughout the course 
of the patient’s ICU stay; deficiencies in any number of institutional factors may 
doom the intervention to failure (185). Krinsley suggests that the need for frequent 
glucose level assessments with TGC, responding to the adjustments in the 
administered treatment, the experience and skill of the nursing staff in the use of 
protocols may affect the probability that the treatment goals are achieved”.  
Moreover, “the structural and organisational characteristics of the ICU may have a 
strong impact on the functioning of  the protocol especially in view of the high work 
burden imposed by TGC-estimated to consume two hours out of a 24-hour 
working day for the ICU nurse (186, 187)”. 
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Instead of TGC, “Krinsley proposed the use of a stepwise approach SEGC. SEGC 
involves the adoption of safe glucose targets appropriate to the skills, experience 
and available tools of the ICU that does not result in a significant risk of 
hypoglycaemia.  The use of appropriate data monitoring tools, both for glucose 
results and relevant clinical outcomes is essential for SEGC. Lastly, the utilisation 
of existing monitoring technologies is mandatory for SEGC”. 
 
“Preliminary clinical evaluations of the accuracy of continuous or near-continuous 
glucose monitors have been published recently from 2005-2010 (23-25). These 
devices offer the promise of a reduction in severe hypoglycaemia, glucose 
variability, the nursing work burden, and will probably become a cornerstone of 
SEGC (188-190)”. 
 
2.15 CONCLUSION 
Hyperglycaemia in the critically ill patients, and the adverse outcomes thereof, has 
been well established.  Protocols are in place in ICUs worldwide to assist with 
glucose control. The overall adherence to glucose control protocols is low. “Reality 
is that deep and dangerous gaps exist between the care that patients should 
receive and care they actually do receive.”  A thought provoking quote by Lavizzo-
Mourey and Berwick (191).  
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2.16 SUMMARY 
An in depth discussion on various aspects of glucose control and protocols in ICU 
has been presented in this chapter. The following chapter will review the research 
methodology of this study. 
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CHAPTER THREE 
RESEARCH DESIGN AND METHODOLOGY 
3.1 INTRODUCTION 
A detailed explanation of the research methodology is discussed under the 
headings: study design, study population and study sample (including sample size, 
sampling method, inclusion and exclusion criteria), description of data collection 
procedures and statistical analysis of the data. 
 
3.2 PROBLEM STATEMENT 
The literature suggests that glucose control in the critical care setting has 
important morbidity and mortality implications. Achieving normoglycaemia during 
this hypermetabolic state, while avoiding hypoglycaemia, is a challenging task.  
Protocols are in place to help achieve glucose targets, however, they may not 
always be followed.  The use of protocols simplifies processes, standardises care, 
facilitates patient safety and reduces costs, but lack of adherence can hinder the 
success of any protocol (30).  Protocols for glucose control are in place in the 
ICUs at Charlotte Maxeke Johannesburg Academic Hospital (CMJAH) but 
adherence to these protocols has not yet been evaluated in the cardiothoracic ICU 
at this institute.  
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The health care workers (HCWs) working in the ICU are from varying academic 
backgrounds.  The nurses are not all ICU trained and some are agency nurses 
whom are employed due to staff shortages. “An audit of all critical care resources 
in South Africa revealed that the majority (49%) of nurses working in critical care 
units in South Africa were registered nurses without critical care training and with 
less than 5 years experience (31).  Specifically, the cardiothoracic ICU at CMJAH 
was found to be staffed, on average, with more than 50% of non-permanent staff 
who were employed on a temporary basis via agencies  (32)”.  
 
3.3 AIM OF THE STUDY 
The aim of the study was to evaluate adherence to the glucose control protocol by 
nurses in the cardiothoracic ICU at CMJAH. 
 
3.4 OBJECTIVES OF THE STUDY 
The research objectives were to: 
• Describe the number of abnormal glucose readings recorded.  
• Describe the proportion of protocol violations in relation to the glucose control 
protocol. 
• Compare the differences in glucose protocol violations between day nursing 
staff and night nursing staff.  
• Compare the level of training of nurses involved with glucose protocol 
violations.  
44 
 
3.5 LOCATION OF STUDY 
The study took place at the cardiothoracic ICU at CMJAH, Gauteng Province, 
South Africa. This is a quaternary, academic hospital associated with the 
University of Witwatersrand. It is the only public sector cardiothoracic ICU in 
Johannesburg. 
 
3.6 ETHICAL CONSIDERATIONS 
Approval to conduct this study was obtained from the Postgraduate Committee 
(Appendix A), the Humans Ethics Committee (medical) of the University of the 
Witwatersrand (Appendix B) and the head of critical care at CMJAH (Appendix D). 
 
In addition, a written informed consent was obtained from the Chief Executive 
Officer (CEO) of CMJAH to conduct the research in the hospital and specifically to 
gain access to, and utilize, patients’ records and nurses’ demographics. 
 
The researcher only worked with numbers allocated to patients and not the file 
numbers or patients’ names. This ensured confidentiality, privacy and anonymity 
of patient information. 
 
Furthermore, anonymity of the nurses working in ICU during the month of March 
2011 was maintained as numbers were allocated to them. The allocated numbers 
of the nurses, not names, was used when reviewing the ICU charts and the 
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researcher only knew the identities of the nurses looking after the patients 
included in the study. The researcher and supervisor were the only people who 
had access to raw data for this study. Data will be kept for a period of 5 years in a 
locked cupboard allowing access only by the researcher. 
 
The retrospective nature of the study did not allow for the researcher to be able to 
intervene with any patient treatment. 
 
The study will be conducted in adherence to the principles of the Declaration of 
Helsinki (35). 
 
3.7 RESEARCH METHODOLOGY 
3.7.1 Study design 
A retrospective, contextual, single-centre descriptive research design will be 
followed in this study. 
 
Retrospective  
“A retrospective study investigates a phenomenon, situation, problem or issue that 
has happened in the past, conducted on the basis that data are available for that 
period (192)”.  Retrospective research often requires the analysis of data that were 
originally collected for reasons other than research (193, 194).  This study is 
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retrospective in nature as it will involve the analyses of recorded data from 
patients’ ICU records from a past period of time i.e. March 2011.  
 
Contextual 
This study will not involve all inpatients but rather a select group of inpatients with 
specific pathophysiological processes i.e. the critically ill patients in a 
cardiothoracic ICU.  
 
De Vos (195) describes context as a “small-scale world” of, amongst others, 
gangs, clinics, hospital wards or critical care units. This study is contextual in 
nature as it will be conducted within a specific context. It will be conducted in a 
public sector academic, Cardiothoracic ICU in Gauteng. 
 
Descriptive 
“A descriptive design is to gain more information about characteristics within a 
particular field of study (37)”. 
 
This study is descriptive in nature as it aims to gain information about adherence 
to the glucose control protocols, as well as the violations thereof, in a 
cardiothoracic ICU. 
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3.7.2 Study population and study sample 
A retrospective review of all ICU charts of adult patients, post cardiac surgery, 
admitted to the CT ICU during the month of March 2011 at CMJAH and the 
demographics of the nurses looking after those patients during that time 
constituted the study sample. 
 
3.7.3 Sample Size 
During this study period, 22 patients were admitted and 741 glucose readings 
were obtained. 
 
3.7.4 Sampling Method 
The reason for choosing this month was that it had the most ICU admissions 
therefore a convenience sampling method was used. This sampling method was 
also chosen due to the scope of the study as well as ease of access to patients’ 
records. This method of sampling is accepted in descriptive research design (196). 
 
3.7.5 Inclusion and exclusion criteria  
Inclusion criteria included the ICU records of all adult patients, 16 years and older, 
admitted to the CT ICU during the month of March 2011 and the demographic data 
of the nurses looking after these patients at the time. 
There were no exclusion criteria. 
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3.7.6 Data collection procedure 
Data collection is the specific, systematic gathering of information relevant to the 
research purpose or the specific objectives and questions of the study (37). 
 
After approval was obtained from the head of the CT ICU at CMJAH, Wits 
University Human Research Ethics Committee (medical), University of 
Witwatersrand and the Chief Executive Officer of CMJAH, the ICU records of all 
adult patients admitted post cardiac surgery during March 2011 admissions 
was reviewed. The data was collected by the researcher personally, from the daily 
ICU charts used both by nurses and physicians in the unit. A data capture record 
was completed using the daily ICU records of patients’ previously admitted to the 
cardiothoracic ICU in March 2011. The data was then entered onto a Microsoft 
Excel spreadsheet. 
 
Data collected included:  
a) Patient data 
• demographic data (age, gender& race) 
• admitting diagnoses 
• insulin dosage according to protocol including insulin infusion 
adjustments 
• blood glucose  
• time of glucose administration 
• length of ICU stay. 
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b) Nursing Data 
• Nurse shift - day shift (07h00-19h00) or night shift (19h00-0700) 
• ICU trained or not ICU trained 
 
3.7.7 Statistical Analysis 
Raw data was captured using an Excel data spreadsheet and analysed using the 
software programme STATA 11 statistical software (STATA Corporation, College 
Station, TX USA). 
 
The following variables were included in the analysis: 
Age (in years), gender, ICU admission procedure, protocol violations, nurse shift 
(day/night), nurse ICU trained (yes/no), length of stay in ICU (days) and glucose 
values. 
 
The results of the study were described and analysed using descriptive and 
inferential statistics. Frequencies and percentages were used summarise the 
categorical data. Mean (age of patients), median IQR and ranges were used to 
summarise the continuous data. Comparisons were made using the chi-square 
test and P-values of <0.05 were considered statistically significant. Missing data 
was still included in the analysis and was charted as ‘’unknown”. 
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3.8 Validity and Reliability 
Validity  
“Validity is the extent to which the instrument actually reflects or measures what it 
is supposed to measure (37)”.  Content validity was secured by literature review, 
experts in intensive care, a biostatistician and research methodologist. 
 
Reliability 
“Reliability is concerned with how consistently the measurement technique 
measures a variable or concept (37)”. The data was collected, from patients’ 
records, by a single researcher only. This ensured that the data is collected in a 
standardised manner and is reliable. 
 
3.9 SUMMARY 
In this chapter, a detailed explanation of the research methodology has been 
presented under the headings of study design, study population and study sample 
(including sample size, sampling method, inclusion and exclusion criteria), 
description of data collection procedure and the planned statistical analysis of the 
data. 
 
The following chapter details the data analysis and discussion of the results of this 
study. 
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CHAPTER FOUR 
DATA PRESENTATION AND DISCUSSION OF RESULTS 
 
4.1 INTRODUCTION 
In this chapter, the results of this study are presented and discussed, in 
accordance with the research objectives.  
 
The research objectives were to: 
• Describe the number of abnormal glucose readings recorded;  
• Describe the proportion of protocol violations in relation to  the glucose 
control protocol;  
• Compare the glucose protocol violations of the day nursing staff and night 
nursing staff;  
• Compare the level of training of nurses involved in protocol violation. 
 
4.2 SAMPLE REALISATION AND APPROACH TO DATA      
ANALYSIS 
The data was collected through a retrospective review of the ICU charts of adult 
patients, post cardiac surgery, who were admitted to the CT ICU at CMJAH during 
the month of March 2011.   
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During this study period, 22 patients were admitted and 741 glucose readings 
were taken. 
 
The results of the study are described and analysed using descriptive and 
inferential statistics. Data that was not available, i.e. information missing from 
charts or unavailable demographic data of nurses were included in the study, but 
charted as “unknown”.  All results were rounded to 2 decimal places.  An abnormal 
glucose value was defined as a glucose value < 4.1 and > 6 mmol/l according to 
the glucose control protocol in place during March 2011 (Appendix G). 
 
4.3 RESULTS 
4.3.1 Demographic Data 
During the data collection period, 22 patients were admitted: 13 (59.1%) male and 
9 (40.9%) female. The mean age of patients was 48.5 years; the age range was 
17 - 76 years.  Figure 4.1 shows the median age and the IQR by gender. 
Figure 4.1 Median age and IQR by gender 
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The median (IQR) length of stay in ICU was 4 (3-5) days, with two patients staying 
in ICU for more than 20 days. 
 
The demographic data of the nursing staff was as follows: 
ICU trained versus non-ICU trained 
• Day shift versus night shift 
 
62.6% (n=464) of the glucose readings were obtained by ICU trained nurses, 
33.2% (n=245) of the readings were obtained by non-ICU trained nurses, and it 
was unknown who obtained 4.2% (n=31) of the readings. 
 
The day shift obtained 46.6% (n=345) of the glucose readings; the night shift 
obtained 51.3% (n=380) of the glucose readings; and it was unknown who 
obtained 2.1% (n=16) of the readings. 
 
The surgical procedures were categorised as: valvular - 77.3% (n=17); coronary - 
13.6% (n=3); and other - 9.1% (n=2).  Table 4.1 shows the specific surgical 
procedures performed during the research period. 
  
54 
 
Table 4.1 Specific type and number of surgical procedures performed 
Variable N (%) 
Surgical procedure   
MVR+TA+MAZE 
DVR 
MVR 
AVR   
CABG 2 vessel 
CABG 3 vessel 
CABG 4 vessel  
AVR+TA 
DVR+TA+MAZE 
AVR+TA+MV REPAIR 
MVR+TA 
Redo DSAS+AVR 
Submitral aneurysm+MVR 
Other 
4 
2 
3 
1 
1 
1 
1 
1 
1 
1 
2 
1 
1 
2 
18.2% 
9.1% 
13.6% 
4.5% 
4.5% 
4.5% 
4.5% 
4.5% 
4.5% 
4.5% 
9.1% 
4.5% 
4.5% 
9.1% 
 
Key: MVR=Mitral Valve Replacement; TA=Tricuspid Annuloplasty; 
MAZE=Ablation of Conduction System of Atria; DVR=Double Valve 
Replacement; AVR=Aortic Valve Replacement; CABG= Coronary Artery Bypass 
Graft; Mitral Valve Repair; DSAS=Discrete Sub-aortic Membrane Stenosis. 
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4.3.2 Number of abnormal glucose readings recorded  
The first objective of the study was to describe the number of abnormal glucose 
readings recorded in adult patients post cardiac surgery in a CT ICU. 
 
An abnormal glucose value was defined as a glucose value < 4.1 and > 6 mmol/l, 
as per glucose control protocol in place during March 2011 (Appendix G). 
 
A total of 741 glucose readings were taken. The median blood glucose 
concentration was 7. 8 mmol/l (IQR 6.7 - 9.3 mmol/l). The median and IQR for 
each patient is shown in Figure 4.2; the range of glucose readings (3.1-17.8 
mmol/l) is shown in Figure 4.3. 
 
Figure 4.2 Median & IQR for glucose values per patient 
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Figure 4.3 Range of glucose readings         
 
Table 4.2 shows the number of glucose readings obtained in the different glucose 
ranges. According to the glucose control protocol in place during March 2011, 629 
(84.9%) of the readings were abnormal, i.e. outside the required glucose range. 
The target range of 4.1-6 mmol/l was only seen in 112 (15.1%) of the glucose 
readings.  
 
Hypoglycaemia (defined in this as a glucose value of less than 4 mmol/l) was 
evident in 7 (0.9%) glucose readings. If the results were analysed according to the 
new glucose protocol currently in place, the target range of 6.1-8 mmol/l would 
have been seen in 279 (37.7%) readings. 
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Table 4.2 Glucose results by category 
Glucose category Number  % Normal Range 
<4 7 0.9 No 
4.1 – 6 112 15.1 Yes 
6.1 – 8 279 37.7 No 
8.1 – 12 300 40.5 No 
12.1 – 14 26 3.5 No 
14.1 – 16 6 0.8 No 
16.1 – 18 11 1.5 No 
>18 0 0 No 
 
4.3.3 To describe the proportion of protocol violations in relation to the 
glucose control protocol 
The next objective of the study was to describe the proportion of protocol 
violations in relation to the glucose control protocol. 
 
During the study period, a total of 741 glucose readings were taken. Overall, 411 
(55.5%) protocol violations were recorded and 18 (2.4%) were unknown. 
 
Figure 4.4 demonstrates the number of glucose readings obtained for each patient 
and the proportion of violations from the glucose control protocol per patient. The 
unknown values are not shown on this figure. 
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Figure 4.4 Protocol violations with respect to glucose readings per patient 
 
Table 4.3 depicts the total number of glucose readings and the number of protocol 
violations for each patient. This table includes the unknown values per patient.  
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Table 4.3 Number of glucose readings and protocol violations per patient 
Patient 
number 
Protocol 
violation 
No protocol 
violation Unknown 
Total glucose 
readings per 
patient 
1 1 9 0 10 
2 15 4 0 19 
3 12 8 6 26 
4 13 10 0 23 
5 15 10 0 25 
6 18 1 0 19 
7 15 18 1 34 
8 21 13 0 34 
9 16 9 0 25 
10 16 22 1 39 
11 9 13 2 24 
12 85 48 0 133 
13 3 6 1 10 
14 7 13 1 21 
15 20 23 2 45 
16 6 6 1 13 
17 2 11 0 13 
18 77 69 0 146 
19 18 7 1 26 
20 15 1 0 16 
21 9 3 1 13 
22 18 8 1 27 
 
411 312 18 741 
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4.3.4 To compare the differences in glucose protocol violations between the 
day nursing staff and night nursing staff 
The next objective of this study was to compare the differences in glucose protocol 
violations between the day nursing staff and night nursing staff. 
 
Day staff work a 07h00-19h00 shift and night staff work from 19h00-07h00. No 
statistically significant difference was found between day nursing staff and night 
nursing staff - X2(1) =1.29, p=0.26. This is shown in Table 4.4. 
 
Table 4.4 Association between day staff and night staff and protocol 
violations 
Variable 
Glucose 
readings  
n (%) 
Protocol 
violations 
n (%) 
Protocol 
violation P value 
Nurse shift 
 - Day 
 - Night 
 
345 (46.6%) 
380 (51.2%) 
 
156 (45.4%) 
156 (41.2%) 
 
188 (54.7%) 
223 (58.5%) 
 
 
       0.26 
 
4.3.5 To compare the level of training of nurses involved with glucose 
control violations 
The last objective of the study was to compare the level of training of nurses 
involved with glucose control violations. 
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A statistically significant difference was found in protocol violations between ICU 
trained and non-ICU trained nursing staff - X2 (1) =6.97, p=0.008. The non-ICU 
trained staff violated the protocol more often. This is shown in Table 4.5.  
 
Table 4.5: Association between ICU training and protocol violations 
Variable 
Glucose 
Readings 
n (%) 
No Protocol 
Violation 
n (%) 
Protocol 
Violation 
P value 
Training 
- ICU trained  
- non-ICU trained  
  
 
464 (62.6%) 
245 (33.2%)  
 
 
216 (46.7%) 
89 (36.3%) 
 
 
247 (53.3%) 
156 (63.7%) 
 
 
 
0.008 
 
4.4 Discussion 
In this study, the proportion of glucose protocol violations was found to be 55.5%. 
This value is higher than that reported by Taylor et al. (25) and Rood et al. (26), 
with  glucose protocol violations reported as 47% and 44% respectively. Oeyen et 
al. (3), reported 29% violations to an insulin protocol. The NICE-SUGAR trial 
reported a 29% violation rate to a glucose control protocol. Possible reasons for 
the lower proportion of violations are that these were large trials conducted in 
developed countries that have adequate resources compared to our local setting.  
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Shift work, and in particular working night shifts, is recognised as a source of 
stress for nurses (197). In a study of 23 Australian nurses, getting less sleep was 
significantly related to an increased likelihood of patient error and a decreased 
likelihood of finding someone else’s error (198). It was this understanding of the 
night nursing staff probably committing more protocol violations than the day staff 
that motivated us to review the timing of protocol violations. However, there was 
no statistical significance between day staff and night staff violations with a p–
value of 0.26. It is beyond the scope of this study to identify reasons for similar 
proportion of violations between day staff and night staff in this study sample. 
 
According to the South African National Audit of Critical Care Resources in 2007, 
there is a national shortage of critical care nurses (31). As a result, there is over-
stretching of the active critical care nurse and a risk of increased workload and 
burnout (31). The workload burden of protocols in the ICU is an important factor to 
consider. In a prospective single-centre study, it was shown that the time required 
for a glucose control protocol to be implemented was 2 hours per day, that is, 
approximately 20% of a nurse’s working day (186). Together with staff shortages 
and highly protocolised ICUs, critical care nurses are under constant pressure to 
deliver safe and effective care to critically ill patients, as well as to impart their 
skills and knowledge to non-ICU trained nurses. In this study, we looked at 
protocol violations between ICU trained and non-ICU trained nurses and, after 
reviewing the literature  were not surprised to find that in our study there were 
more protocol violations by the non-ICU trained nurses; a p-value of 0.008. 
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For a protocol to be efficiently developed and implemented, its feasibility should be 
tailored according to resource availability in that setting. All health care workers 
involved in patient care (nurses, doctors, nutritionists, etc,) need to work together 
in order to facilitate this process. Other health care workers involved with 
implementation of the glucose control protocol were not evaluated in this study, 
but are equally responsible, as nurses, in implementing protocols. 
 
Protocol violation may or may not compromise patient care. Conducting an audit of 
practice in ICUs assists in identifying the reasons for violations. In 2008, Gupta et 
al. (199) reported a case of accidental severe hypoglycaemia and 
neuroglycopaenia caused by an arterial line flush error. The fluid used as the 
arterial line flush was normal saline with dextrose, instead of plain normal saline. 
As a result, falsely high glucose readings were taken from blood samples from the 
arterial line as a saline/glucose flush had been used. Insulin was used to treat 
these erroneously high glucose readings, according to the glucose control protocol 
in place in that ICU at that time. This resulted in the patient suffering severe 
hypoglycaemia and neuroglycopaenia. 
 
This is just one of several examples in which even though the action was not 
strictly a protocol violation, it did demonstrate how a simple error can lead to an 
adverse patient outcome.  
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According to Wong et al. (200), “one of the cardinal concepts, (borrowed from 
industry), in patient safety, is systems analysis. This is the concept that system 
failure, not individual human failure, is to blame for many of the adverse events 
occurring in health care. An important part of moving beyond the blame and 
punishment often associated with medical error is recognizing that the human 
factor is only one aspect of today’s complicated medical system”. “Preventing 
errors and improving safety for patients require a systems approach in order to 
modify the conditions that contribute to errors. People working in health care are 
among the most educated and dedicated work force in any industry. The problem 
is not bad people; the problem is that the system needs to be made safer.” A 
saying which also needs to be kept in mind is “To err is human” (201). 
 
Other possible causes for protocol violations include: 
• “interaction with technology 
• the large number of health care staff involved in the provision of care, 
resulting in multiple hand-overs 
• poor communication between patients and staff and poor staff-staff 
communication 
• stress and fatigue 
• human factor design flaws 
• lack of appropriate education and training 
• higher acuity of illness 
• the need for rapid decision-making 
• reduction in staffing 
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• a lack of redundancies to prevent error (201)”. 
 
Cabana et al. (202) identified barriers to adherence to practice guidelines. In their 
model, “barriers to knowledge include lack of awareness and familiarity with 
guidelines. Barriers to attitude include lack of agreement with guidelines, lack of 
self-efficacy, lack of outcome expectancy and lack of motivation. Barriers to 
behaviour include factors related to patients (e.g. patient expectation), the practice 
environment (e.g. lack of time; or resources) and the guidelines themselves (e.g. 
conflicting recommendations). These categories are indicated in Table 4.6. 
 
Table 4.6 Summary of Cabana’s barriers to using guidelines (202) 
Physician Attribute Barriers 
Knowledge 
Lack of awareness 
Lack of familiarity 
Attitude 
Lack of agreement 
Lack of self-efficacy* 
Lack of outcome expectancy** 
Inertia of previous practice 
Behaviour 
External barriers 
• Patient related barriers 
• Environmental related barriers 
• Guideline related barriers 
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* Lack of self-efficacy: self-efficacy is the belief that one can perform a 
task. 
** Lack of outcome expectancy: outcome expectancy is the belief that if one 
carries out the task it will make a difference to patient outcomes”. 
 
Although adherence to the protocol was poor, the median (IQR)  glucose reading 
was 7.8 mmol/l. Locally, the Nesibopho Best Practice Guidelines (175) on glucose 
control in ICU, (which is endorsed by the Critical Care Society of Southern Africa), 
recommends the maintenance of glucose to be <8.1 mmol/l; but if monitoring is 
inadequate or hypoglycaemia occurs, maintenance should be between 7-9 mmol/l. 
Therefore the glucose value being obtained in the CT ICU, despite resource 
constraints and protocol violations, was found to still be within a reasonable range. 
  
The benefits and risks of TGC has been an ongoing debate, but there seems to be 
a move towards SEGC rather than TGC (185). Despite the morbidity and mortality 
implications of TGC, the work burden of implementing TGC is difficult in the local 
setting, as highlighted by a national audit of resources in the critical care setting, 
which showed a shortage of skilled nursing staff (31). Therefore, the finding of a 
statistically significant proportion of protocol violations by non-ICU trained nursing 
staff in this study bears further evidence of the shortage of skilled nursing staff in 
ICUs, which then impacts on patient safety. An important point to note from the 
landmark Leuven 1 trial (7) was that TGC in the ICU was possible due to 
adequacy of nursing staff- hence hypoglycaemic episodes were reduced. 
However, this is not feasible in most critical care settings. 
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Glucose control is difficult in critically ill patients and the target glucose range is 
not always met. The exact incidence of hospital hyperglycaemia is not known, but 
it varies based on study populations and definitions utilised in previous reports. 
Two observational studies, which used 7.8 mmol/ as hyperglycaemia, found 
hyperglycaemia in 80% of critically ill patients after cardiac surgery (12, 13).  The 
occurrence of hyperglycaemia is even more evident in critically ill patients; 31% of 
the population will have at least one BG reading >11.1 mmol/l and nearly 100% 
will have a BG > 6.1 mmol/l during their ICU stay (7, 10, 14). 
 
“Based on the results of recent trials, the American Association of Clinical 
Endocrinologist and American Diabetes Association task force on inpatient 
glucose control, it was recommended that targeting a BG level between 7.8 and 
10.0 mmol/l for the majority of ICU patients and a lower glucose target between 
6.1 and 7.8 mmol/l  in selected ICU patients (i.e. centres with extensive experience 
and appropriate nursing support, cardiac surgical patients and patients with stable 
glucose control without hypoglycaemia) (203). Glucose targets >10 mmol/l or < 6.1 
mmol/l are not recommended in ICU patients (74, 79)”. 
 
In this study, the target glucose range during March 2011 in the CT ICU was 4.1-6 
mmol/l. This target range was only seen in 15.1% of glucose readings with the 
number of abnormal readings being 84.9% (n=629).  According to the new glucose 
control protocol that is now implemented in the CT ICU, the target range is 6.1-8 
mmol/l.  This target range would therefore be seen in 37.7% of the readings. 
68 
 
4.5 CONCLUSION 
“One of the most consistent findings in research on health services is the gap 
between evidence and practice (43)”.  Evidence-based protocols and guidelines 
are utilised to assist not only with patient clinical management and to reduce the 
guess work from patient care, but to also reduce the work load on nursing staff as 
a short term solution to skilled staff shortages (104). The finding of a substantial 
proportion of protocol violations in the ICU highlights the necessity of further 
education and ongoing assessments of implemented protocols by all health care 
workers involved with patient care. 
 
4.6 SUMMARY 
In this chapter the results of the study were presented, as per the research 
objectives, and discussed.  The data presented included: the sample realisation; 
the demographic data of the study sample; the number of abnormal glucose 
readings recorded from adult patients post cardiac surgery in a CT ICU; the 
proportion of protocol violations from the glucose control protocol used in ICU, the 
differences in glucose protocol violations between day nursing staff and night 
nursing staff and the level of training of ICU nursing staff involved with protocol 
violation. The findings were described and analysed using descriptive and 
inferential statistics. 
 
69 
 
In the final chapter a summary is presented, together with the limitations, 
recommendations and a conclusion of the study. 
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CHAPTER 5 
 
SUMMARY, LIMITATIONS, RECOMMENDATIONS AND 
CONCLUSION 
 
5.1 INTRODUCTION 
In this chapter, the aim, objectives, study design and results of the study will be 
reviewed briefly. The limitations of the study will be addressed, recommendations 
made to improve clinical practice and suggestions provided for areas of further 
research. Finally, a conclusion is presented. 
 
5.2 SUMMARY OF THE STUDY 
 
5.2.1 Aim of the study 
The aim of the study was to evaluate adherence to the glucose control protocol by 
nurses in the cardiothoracic ICU at CMJAH. 
 
5.2.2 Objectives of the study 
The research objectives were to: 
• Describe the number of abnormal glucose readings recorded.  
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• Describe the proportion of protocol violations in relation to the glucose control 
protocol. 
• Compare the differences in glucose protocol violations between day nursing 
staff and night nursing staff.  
• Compare the level of training of nurses involved with glucose protocol 
violations.  
 
5.2.3 Summary of methodology used in the study 
A retrospective, contextual, single-centre descriptive research design was used in 
this study. The ICU charts of all adult patients, post cardiac surgery, admitted to 
the CT ICU during March 2011 at CMJAH and the demographics of the nurses 
working in the unit for that period of time were reviewed and this constituted the 
study sample. The reason for choosing this month was that it had the highest 
number of ICU admissions during the research period. A convenience sampling 
method was employed.  
 
The glucose control protocol in place in ICU at the time of conducting the study 
was defined. 
 
Inclusion and exclusion criteria were also defined. The data collected was 
analysed using STATA 11 statistical software.  
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The results of the study were described and analysed using descriptive and 
inferential statistics. Frequencies and percentages were used summarise the 
categorical data. Mean (age of patients), median IQR and ranges were used to 
summarise the continuous data. Comparisons were made using the chi-square 
test and P-values of <0.05 were considered statistically significant. 
 
5.2.4 Main findings of the study 
Twenty-two patients’ ICU charts were entered in the study and a total of 741 
glucose readings evaluated. The median glucose reading was 7.8 mmol/l (6.7- 9.3 
mmol/l). Of the 741 readings, 629 (84.9%) were abnormal (i.e. outside the required 
target range) according to the glucose control protocol at the time. Overall, the 
proportion of protocol violations was 55.5%.  
 
Protocol violations were similar between day and night staff, i.e.188 (54.7%) and 
223 (58.5%) respectively (p =0.256). 
 
Of the total glucose readings, 463 (65.4%) were done by ICU trained nurses and 
245 (34.6%) by non-ICU trained nurses.  
 
There were fewer protocol violations recorded by ICU trained nurses as opposed 
to non-ICU trained nurses, i.e. 53.3% and 63.7% respectively (p<0.05).   
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5.3 LIMITATIONS OF THE STUDY 
This study has the following limitations. 
This study was done contextually at CMJAH and the results may not be 
generalisable to other ICUs. 
 
It was unknown what the sample size would be until the data was collected (as we 
did not know how many blood glucose readings would be done in one month) and 
therefore were unable to calculate the sample size necessary to find this 
difference so the results should be interpreted with caution as they may be 
underpowered. 
 
A study by Kanji et al. (168) confirmed that there may be clinically relevant 
disparities between different methods of glucose measurement. The “gold 
standard” of blood glucose measurement involves a blood sample being sent to 
the laboratory for the most accurate result; however, this was not feasible in this 
study. Most glucose values in this study were identified by blood gas analysis; 
however it was not distinguished on the chart when a point of care machine was 
used or when an arterial blood sample and a venous blood sample were used. 
Using arterial blood sample compared to venous blood sample being more 
accurate for glucose measurement.  A single standardised method of glucose 
measurement should ideally be used; however, this study is a reflection of day to 
day practice in the ICU. 
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Lastly other limitations of a retrospective study are that it relies on the accuracy of 
written record or recall by individuals (recall bias), as well as legibility and 
availability of records. In this study, determining nursing demographic data posed 
a challenge, as data was obtained from poorly kept shift records and via word of 
mouth.  Therefore, it is possible that there was a loss of important data and that 
inaccurate data was collected. 
 
5.4 RECOMMENDATIONS FROM THE STUDY 
5.4.1 Recommendations for clinical practice 
The workload burden of implementing a glucose control protocol in our ICU setting 
is notable. A trend towards SEGC, rather than TGC is a more manageable 
approach to glucose control. 
 
Due to the severity of illness in critically ill patients, the rapid advancement in 
technology and the emergence of new information, all health care workers need to 
be up to date and well acquainted with the literature in order to provide safe, 
quality care to patients. Educational programmes need to be implemented, for all 
health care workers in ICU. All programmes should be updated and presented 
regularly to new health care workers in the CT ICU. 
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There is a gap between research and practice. There should be regular audits of 
clinical practice to ensure that what is prescribed for the patient is actually the care 
given. 
 
5.4.2 Recommendations for further research  
Education of health care workers and follow up questionnaires on the 
understanding and implementation of local protocols. 
 
Evaluate and identify factors responsible for protocol violation and target those 
factors in order to improve adherence to any protocol implemented in ICU. As 
proposed by Cabana et al. (202) mentioned in the previous chapter where the 
knowledge, attitudes and behaviour of health care workers should be evaluated 
when implementing a protocol. Furthermore, a systems analysis approach should 
be considered for implementation of future protocols (200). 
 
The literature has revealed a large number of studies involving computerised and 
closed-loop protocol implementation with improved adherence to the protocol. 
These types of protocols will be used in future for further research into protocol 
implementation. 
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5.5 CONCLUSION 
Adherence to the glucose control protocol in the CT ICU was poor.  Despite a high 
percentage of protocol violations, the median blood glucose level was 7.8 mmol/l. 
The number of violations committed by day staff and night staff were similar and 
not statistically significant. ICU trained nurses committed fewer violations than 
non-ICU trained nurses and this was statistically significant.  
 
These results suggest that the training and education of healthcare workers in 
implementing protocols is an ongoing and dynamic process and evaluation is 
needed on a regular basis. 
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APPENDIX E 
DATA COLLECTION SHEET (A) 
Day of ICU ______ Patient study number __________  Date__________ 
 
 
  
06:00 
-BG 
-Tx 
-Violation Y/N 
Nurse No:   
 
 
 
07:00 
-BG 
-Tx 
-Violation Y/N 
Nurse No: 08:00 
-BG 
-Tx 
-Violation Y/N 
Nurse No: 
09:00 
-BG 
-Tx 
-Violation Y/N 
Nurse No:   10:00 
-BG 
-Tx 
-Violation Y/N 
Nurse No: 11:00 
-BG 
-Tx 
-Violation Y/N 
Nurse No: 
12:00 
-BG 
-Tx 
-Violation Y/N 
Nurse No: 13:00 
-BG 
-Tx 
-Violation Y/N 
Nurse No: 14:00 
-BG 
-Tx 
-Violation Y/N 
Nurse No: 
15:00 
-BG 
-Tx 
-Violation Y/N 
Nurse No: 16:00 
-BG 
-Tx 
-Violation 
Y/N
  
Nurse No: 
 
17:00 
-BG 
-Tx 
-Violation Y/N 
Nurse No: 
18:00 
-BG 
-Tx 
-Violation Y/N 
Nurse 
No:
  
19:00 
-BG 
-Tx 
-Violation Y/N 
Nurse No: 20:00 
-BG 
-Tx 
-Violation Y/N 
Nurse No: 
21:00 
-BG 
-Tx 
-Violation Y/N 
Nurse 
No:
  
22:00 
-BG 
-Tx 
-Violation Y/N 
Nurse No: 23:00 
-BG 
-Tx 
-Violation Y/N 
Nurse No: 
00:00 
-BG 
-Tx 
-Violation Y/N 
Nurse No:    01:00 
-BG 
-Tx 
-Violation Y/N 
Nurse No: 02:00 
-BG 
-Tx 
-Violation Y/N 
Nurse No: 
03:00 
-BG 
-Tx 
-Violation Y/N 
Nurse No: 04:00 
-BG 
-Tx 
-Violation Y/N 
Nurse No: 05:00 
-BG 
-Tx 
-Violation Y/N 
Nurse No: 
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APPENDIX F 
DATA COLLECTION SHEET (B) 
Nurses Demographic Data 
1. Nurse research number   
  
 
 
2.  Nurse qualification   
    
     
 
 
   
3. Years of ICU experience     
   
 
 
4. Permanent/Agency staff     
  
 
 
5. Permanent Day/Night staff      
 
 
         
ICU trained 
professional 
nurse 
 
Professional 
nurse 
 
Staff nurse  
Auxiliary nurse  
Data not 
available 
 
Data not 
available 
 
Data not 
available 
 
Data not available  
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APPENDIX G 
INSULIN SLIDING SCALE PROTOCOL 
BG (mmol/l) Rapid acting insulin (Subcutaneous) 
 
 
 
<4 
 
NIL 
Treat as hypoglycaemia 
1. Call medical doctor. 
2. Administer 25 ml of DW50 
3. Recheck BG every 15 minutes until >5 mmol/l 
4. Thereafter recheck BG hourly 
 
4.1-6 
 
0 U 
 
6.1-8 
 
1U 
 
8.1-12 
 
2U 
 
12.1-14 
 
4U 
 
14.1-16 
 
6U 
 
16.1-18 
 
8U 
 
18.1-20 
 
10U 
 
> 20 
 
12U and call medical doctor 
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APPENDIX H 
 
INSULIN INFUSION PROTOCOL 
 
100 UNITS INSULIN (ACTRAPID) IN 100 mls NORMAL SALINE 
THEREFORE: 1 ml = 1 unit of insulin 
 
The aim is to keep the blood glucose level between 4 - 6 mmol/l 
 
If at any time prior to starting the insulin infusion the blood glucose is  
6.1 mmol/l or greater, repeat it one hour later.  If the repeat blood glucose is still 
greater than 6.1 mmol/l start the insulin infusion as per protocol. 
 
Start the insulin infusion at 2 units per hour and repeat the dextrostix 
one hour later: 
 
 If blood glucose < 3 mmol/l → stop insulin infusion, give 50 mls of  
50% dextrose water IV and repeat dextrostix after 15 min and again after 30 
min. 
 
If blood glucose = 3- 4 mmol/l → stop infusion and repeat dextrostix after 
30 min.  Restart insulin infusion if repeat dextrostix is > 8 mmol/L. 
 
If blood glucose = 4-6 mmol/l → continue infusion and repeat dextrostix 
after 2 hours. 
 
If blood glucose = 6-8 mmol/l → increase insulin infusion by 1 unit per hour 
and repeat dextrostix after 1 hour. 
 
If blood glucose = > 8 mmol/l → increase insulin infusion by 2 units per 
hour and repeat dextrostix after 1 hour. 
 
If blood glucose is stable (i.e. 4-6 mmol/l) for longer than 12 hours on a 
constant insulin infusion the dextrostix can be done 4 hourly. 
 
NB Stop insulin infusion if feeds or TPN are stopped or if patient develops 
intolerance for feeds.  For patients who are discharged to the ward and in 
whom the insulin infusion has been stopped, flush the line/port that the 
insulin infusion was connected to with 5 ml N/Saline. 
 
 
 
 
